Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EADO 2020 | Impact of COVID-19 on melanoma treatment

Bettina Ryll • 13 Oct 2020
EADO 2020
Skin Cancer

Bettina Ryll, MD, PhD, Melanoma Patient Network Europe, Uppsala, Sweden, explores the impact of the COVID-19 pandemic on the treatment and management of patients with melanoma. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Bettina Ryll

3:25
Access to novel therapies in melanoma
Bettina Ryll • 14 Oct 2020
2:12
Melanoma Patient Network Europe
Bettina Ryll • 14 Oct 2020
2:05
ECCO 2017: treatment value vs affordability
Bettina Ryll • 27 Jan 2017
1:03
The Medicines Adaptive Pathways to Patients (MAPPs) and its importance in oncology
Bettina Ryll • 7 Oct 2016

Related Videos

1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
2:12
Novel immunotherapeutic approaches to treat patients with melanoma
Christoffer Gebhardt • 9 Apr 2024
1:22
INTerpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
Christoffer Gebhardt • 9 Apr 2024
2:15
Reducing the need for sentinel node biopsies in cutaneous melanoma
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals